Answers are grounded in this paper and cite their sources.
Background: Asthma is a prevalent reversible airway disorder. Traditional Chinese medicine herbs Farfarae Flos and Pseudostellaria heterophylla may have therapeutic effects, but their mechanisms remain unclear. Objectives: To identify active components, key targets and molecular mechanisms of these herbs in asthma treatment via network pharmacology, molecular docking and gene expression validation. Methods: Active compounds and targets were screened from TCMSP (OB≥30%, DL≥0.18). Asthma-related targets were retrieved from GeneCards, DrugBank and OMIM. PPI network analysis, GO/KEGG enrichment and molecular docking were performed. PTGS2 expression was validated using GEO data. Results: A total of 176 targets were identified for Farfarae Flos, 74 for Pseudostellaria heterophylla and 242 for asthma, yielding 15 common targets. GO enrichment involved cytokine activity and prostaglandin-endoperoxide synthase activity; KEGG highlighted HIF-1, IL-17, C-type lectin and TNF pathways. Docking predicted that quercetin, luteolin and kaempferol had strong binding to PTGS1/PTGS2. PTGS2 expression was significantly upregulated in asthma patients versus healthy controls. Conclusion: These herbs may exert predicted potential activity through multi-component, multi-target and multi-pathway mechanisms, with PTGS1/PTGS2 as core targets and quercetin/luteolin/kaempferol as potential active ingredients.
No takes yet. Share an insight, caveat, or question.
Yunlai Wu (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: